South & Central America Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product, Disease Indication, Procedure, and End User

List of Tables

The embolotherapy market in South & Central America is expected to grow from US$ 230.83 million in 2022 to US$ 339.16 million by 2028. It is estimated to grow at a CAGR of 6.6% from 2022 to 2028.

Rising Prevalence of Cancer Fuels Embolotherapy Market in South & Central America

The five most common types of cancer are breast, prostate, cervical, lung, and colorectal. However, of these five cancers, the leading cause of cancer-related death is lung cancer. Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. Embolization is used to stop bleeding or block blood flow to a tumor or abnormal area of tissue. It is also used to treat liver and kidney cancer and neuroendocrine tumors. Embolizing agents, including embolic microspheres (beads), are used to restrict the vascular supply of tumors, and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. The vascular embolization device (previously the arterial embolization device) is intended to control hemorrhaging due to aneurysms, certain types of tumors, and arteriovenous malformations. The pipeline embolization device is used for the treatment of large and giant wide-neck intracranial aneurysms in the internal carotid artery. It helps prevent aneurysms and tumors from growing and causing harm to essential organs. Thus, the rising prevalence of cancer cases is creating a high demand for embolotherapy products.

Market Overview

The embolotherapy market in South & Central America is segmented into Brazil, Argentina, and the rest of SAM . In 2021, Brazil held the largest market share. Also, the market in the country is projected to grow at the highest rate during the forecast period. The embolotherapy market in the region is expected to grow in the coming years owing to the rising prevalence of cancer and improving healthcare facilities in the countries. Brazil is the largest revenue-generating country for the embolotherapy market in South & Central America. Moreover, it is one of the fastest-growing economies across the world. Cancer is one of the primary epidemic diseases, and the number of cancer cases has doubled in the past three decades..

South & Central America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Embolotherapy Market Segmentation

The South & Central America embolotherapy market is segmented into product, disease indication, procedure, end user, and country.

Based on product, the market is segmented into embolic agents and support devices. The embolic agents segment registered the largest market share in 2022. Based on disease indication, the market is categorized into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held the largest market share in 2022. Based on procedure, the South & Central America embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2022. Based on end user, the South & Central America embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. Based on country, the market is segmented into Brazil, Argentina, and Rest of SAM. Brazil dominated the market share in 2022. Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation are the leading companies operating in the embolotherapy market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America embolotherapy market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America embolotherapy market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the embolotherapy market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00027552

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 South & Central America Embolotherapy Market - by Product
- 1.3.2 South & Central America Embolotherapy Market - by Disease Indication
- 1.3.3 South & Central America Embolotherapy Market - by Procedure
- 1.3.4 South & Central America Embolotherapy Market - by End User
- 1.3.5 South & Central America Embolotherapy Market- By Country

2. South & Central America Embolotherapy Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Embolotherapy Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion

5. South & Central America Embolotherapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Burgeoning Incidence of Cancer Cases
- 5.1.2 Broadening Patient Preference for Minimally Invasive Procedures
5.2 Market Restraints
- 5.2.1 Access of Other Alternative Therapies
5.3 Market Opportunity
- 5.3.1 Elevating Applications of Embolotherapy
5.4 Market Trend
- 5.4.1 Widening Use of Liquid Embolic Agents
5.5 Impact analysis

6. South & Central America Embolotherapy Market Analysis

6.1 South & Central America Embolotherapy Market Revenue Forecast and Analysis

7. South & Central America Embolotherapy Market - by Product

7.1 Overview
7.2 South & Central America Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
7.3 Embolic Agents
- 7.3.1 Overview
- 7.3.2 Embolic Agents: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Microspheres
  - 7.3.3.1 Overview
  - 7.3.3.2 Microspheres: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Embolic Coils
  - 7.3.4.1 Overview
  - 7.3.4.2 Embolic Coils: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.5 Embolic Plug Systems
  - 7.3.5.1 Overview
  - 7.3.5.2 Embolic Plug Systems: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.6 Detachable Balloons
  - 7.3.6.1 Overview
  - 7.3.6.2 Detachable Balloons: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.7 Liquid Embolic Agents
  - 7.3.7.1 Overview
  - 7.3.7.2 Liquid Embolic: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.8 Others
  - 7.3.8.1 Overview
  - 7.3.8.2 Others: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Support Devices
- 7.4.1 Overview
- 7.4.2 Support Devices: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 Microcatheters
  - 7.4.3.1 Overview
  - 7.4.3.2 Microcatheters: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 Guidewires
  - 7.4.4.1 Overview
  - 7.4.4.2 Guidewires: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Embolotherapy Market Analysis - by Disease Indication

8.1 Overview
8.2 South & Central America Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
8.3 Cancer
- 8.3.1 Overview
- 8.3.2 Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.1 Liver Cancer
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 Liver Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.2 Kidney Cancer
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Kidney Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.3 Other Cancers
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Other Cancers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Peripheral Vascular Diseases
- 8.4.1 Overview
- 8.4.2 Peripheral Vascular Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Neurological Diseases
- 8.5.1 Overview
- 8.5.2 Neurological Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Urological and Nephrological Disorders
- 8.6.1 Overview
- 8.6.2 Urological and Nephrological Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Gastrointestinal Disorders
- 8.7.1 Overview
- 8.7.2 Gastrointestinal Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Embolotherapy Market Analysis - by Procedure

9.1 Overview
9.2 South & Central America Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
9.3 Transcatheter Arterial Embolization (TAE)
- 9.3.1 Overview
- 9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
- 9.4.1 Overview
- 9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Transarterial Chemoembolization (TACE)
- 9.5.1 Overview
- 9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Embolotherapy Market Analysis - By End User

10.1 Overview
10.2 South & Central America Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgical Centers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Other End Users
- 10.5.1 Overview
- 10.5.2 Other End Users: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

11. South & Central America Embolotherapy Market - Country Analysis

11.1 Overview
- 11.1.1 South & Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)
  - 11.1.1.1 Brazil: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.1.1 Brazil: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.1.2 Brazil Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.1.2.1 Brazil Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.1.2.2 Brazil Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.1.3 Brazil Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.1.3.1 Brazil Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.1.4 Brazil Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.1.5 Brazil Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.1.1.2 Argentina: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.2.1 Argentina: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.2.2 Argentina Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.2.2.1 Argentina Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.2.2.2 Argentina Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.2.3 Argentina Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.2.3.1 Argentina Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.2.4 Argentina Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.2.5 Argentina Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.1.1.3 Rest of South and Central America: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.3.1 Rest of SAM: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.3.2 Rest of SAM Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.3.2.1 Rest of SAM Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.3.2.2 Rest of SAM Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.3.3 Rest of SAM Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.3.3.1 Rest of SAM Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.3.4 Rest of SAM Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.1.3.5 Rest of SAM Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)

12. South & Central America Embolotherapy Market -Industry Landscape

12.1 Overview
12.2 Organic Developments
- 12.2.1 Overview
12.3 Inorganic Developments
- 12.3.1 Overview

13. Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Boston Scientific Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Cook Medical LLC
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Johnson & Johnson
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Medtronic
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Acandis GmbH
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Balt USA LLC
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Stryker Corporation
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Guerbet LLC
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Terumo Corporation
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms